UnknownNot Applicable

Prevalence and Characterization of Pain in RASopathies

Italy150 participantsStarted 2021-01-27

Plain-language summary

RASopathies are a group of syndromes caused by variants in genes belonging to the RAS/MAPK pathway. Pain is a neglected topic in RASopathies but it is frequently complained by affected individuals.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All individuals with clinical and molecularly confirmed diagnosis of a RASopathy Exclusion Criteria: * Individuals with a RASopathy con confirmed by genetic analysis

What they're measuring

Prevalence of pain in verbal patients with RASopathies

Timeframe: 2 years

Prevalence of Pain in no-communitating patients with RASopathies

Timeframe: 2 years

Trial details

NCT IDNCT06355622

SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-30

Contact for this trial

Chiara Leoni, MD, PhD

0039063381344 chiara.leoni@policlinicogemelli.it

View on ClinicalTrials.gov More RASopathy trials